Broker Regulation

President Barack Obama isn't talking about it and neither is Mitt Romney. But come January, 163 million workers can expect to feel the pinch of a big tax increase regardless of who wins the election.

Orexigen Therapeutics Inc. said Monday it is in discussions with the Food and Drug Administration about speeding up a regulatory review of Orexigen's obesity drug Contrave.

For organizations with employer-owned life insurance, which is a policy owned by an entity that acts as the beneficiary, there is the potential for major tax savings. But employers must be sure they are following all of the regulations in order to see that tax advantage.

Though Barack Obama and Mitt Romney rarely tackle the topic of abortion head-on, the void is being filled by rival advocacy groups targeting swing states with ads depicting one or the other candidate as an extremist in his stance on the divisive issue.

WebMD extended its poison pill defense, first put into place to ward off billionaire investor Carl Icahn, for another two years.

President Barack Obama and Republican challenger Mitt Romney are returning to the sometimes-nasty rhetoric of a close presidential campaign after a brief truce, renewing their focus on two battleground states and preparing for next week's final, perhaps pivotal, debate.